These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Potential and novel therapies for asthma. Babu KS; Holgate ST J Assoc Physicians India; 2000 Nov; 48(11):1096-102. PubMed ID: 11310390 [TBL] [Abstract][Full Text] [Related]
25. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma. Kierstein S IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308 [No Abstract] [Full Text] [Related]
26. Ethics of placebos in clinical asthma trials. Coffey MJ; Ross LF J Allergy Clin Immunol; 2006 Feb; 117(2):470; author reply 470-1. PubMed ID: 16461154 [No Abstract] [Full Text] [Related]
27. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma]. Michils A; Sternon J J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881 [TBL] [Abstract][Full Text] [Related]
28. Update on glucocorticoid action and resistance. Ito K; Chung KF; Adcock IM J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450 [TBL] [Abstract][Full Text] [Related]
29. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Karish SB; Gagnon JM Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669 [TBL] [Abstract][Full Text] [Related]
35. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma. Spahr JE; Krawiec ME Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146 [TBL] [Abstract][Full Text] [Related]